Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Jan 7;42(1):77-88.
doi: 10.1039/c2cs35216h. Epub 2012 Sep 26.

BODIPY dyes in photodynamic therapy

Affiliations
Review

BODIPY dyes in photodynamic therapy

Anyanee Kamkaew et al. Chem Soc Rev. .

Abstract

BODIPY dyes tend to be highly fluorescent, but their emissions can be attenuated by adding substituents with appropriate oxidation potentials. Substituents like these have electrons to feed into photoexcited BODIPYs, quenching their fluorescence, thereby generating relatively long-lived triplet states. Singlet oxygen is formed when these triplet states interact with (3)O(2). In tissues, this causes cell damage in regions that are illuminated, and this is the basis of photodynamic therapy (PDT). The PDT agents that are currently approved for clinical use do not feature BODIPYs, but there are many reasons to believe that this situation will change. This review summarizes the attributes of BODIPY dyes for PDT, and in some related areas.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Binding of a functionalized BODIPY to the inositol 1,4,5-trisphosphate receptor places the PDT agent in a hydrophobic environment where singlet oxygen generation is favored, leading to inactivation of the protein.
Figure 2
Figure 2
Excitation of bisBODIPY systems like 26 gives singlet excited states (blue electrons), but a triplet state (red) is also favored.

Similar articles

Cited by

References

    1. Agostinis P, Berg K, Cengel Keith A, Foster Thomas H, Girotti Albert W, Gollnick Sandra O, Hahn Stephen M, Hamblin Michael R, Juzeniene A, Kessel D, Korbelik M, Moan J, Mroz P, Nowis D, Piette J, Wilson Brian C, Golab J. CA Cancer J Clin. 2011;61:250–281. - PMC - PubMed
    1. Dolmans DEJGJ, Fukumura D, Jain RK. Nat. Rev. Cancer. 2003;3:380–387. - PubMed
    1. Moan J, Berg K. Photochem. Photobio. 1991;53:549–553. - PubMed
    1. Juarranz A, Jaen P, Sanz-Rodriguez F, Cuevas J, Gonzalez S. Clin. Transl. Oncol. 2008;10:148–154. - PubMed
    1. Castano AP, Demidova TN, Hamblin MR. Photodiag. Photodyn. Ther. 2004;1:279–293. - PMC - PubMed

Publication types

MeSH terms

Substances